{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:14:02Z","timestamp":1789859642918,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.hpb.2022.09.003","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T03:27:35Z","timestamp":1663212455000},"page":"2134-2144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Contribution of germline PALB2 variants to an unselected and prospectively registered pancreatic cancer patient cohort in Pakistan"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6811-5064","authenticated-orcid":false,"given":"Noor","family":"Muhammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rida","family":"Sadaqat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humaira","family":"Naeemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6000-6656","authenticated-orcid":false,"given":"Iqra","family":"Masood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1826-8104","authenticated-orcid":false,"given":"Usman","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Ijaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6504-4026","authenticated-orcid":false,"given":"Aamir A.","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed A.","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7684-3122","authenticated-orcid":false,"given":"Muhammad U.","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2022.09.003_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2022.09.003_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"10.1016\/j.hpb.2022.09.003_bib4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3748\/wjg.v23.i6.935","article-title":"Familial pancreatic cancer: concept, management and issues","volume":"23","author":"Matsubayashi","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2022.09.003_bib5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.11137","article-title":"Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing","volume":"318","author":"Mandelker","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.hpb.2022.09.003_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1158\/2159-8290.CD-15-0402","article-title":"Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer","volume":"6","author":"Roberts","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.hpb.2022.09.003_bib7","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2018.6228","article-title":"Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer","volume":"319","author":"Hu","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.hpb.2022.09.003_bib8","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1200\/JCO.2017.72.3502","article-title":"Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma","volume":"35","author":"Shindo","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2022.09.003_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00098","article-title":"Reflex testing for germline BRCA1, BRCA2, PALB2, and ATM mutations in pancreatic cancer: mutation prevalence and clinical outcomes from two Canadian research registries","volume":"2","author":"Smith","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.hpb.2022.09.003_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1959","article-title":"PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene","volume":"39","author":"Rahman","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.hpb.2022.09.003_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1171202","article-title":"Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene","volume":"324","author":"Jones","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.hpb.2022.09.003_bib12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.19.01907","article-title":"Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families","volume":"38","author":"Yang","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2022.09.003_bib14","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41436-021-01151-8","article-title":"Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Tischkowitz","year":"2021","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.hpb.2022.09.003_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00535-021-01806-y","article-title":"A\u00a0systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer","volume":"56","author":"Astiazaran-Symonds","year":"2021","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.hpb.2022.09.003_bib16","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/MPA.0000000000000574","article-title":"Clinicopathologic features and germline sequence variants in young patients (\u226440 Years old) with pancreatic ductal adenocarcinoma","volume":"45","author":"Ohmoto","year":"2016","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.hpb.2022.09.003_bib17","first-page":"8105","article-title":"Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma","volume":"8","author":"Takeuchi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.hpb.2022.09.003_bib18","doi-asserted-by":"crossref","first-page":"74227","DOI":"10.18632\/oncotarget.12490","article-title":"Germline mutations in Japanese familial pancreatic cancer patients","volume":"7","author":"Takai","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.hpb.2022.09.003_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103033","article-title":"Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes","volume":"60","author":"Mizukami","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.hpb.2022.09.003_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.48721","article-title":"Prevalence of germline sequence variations among patients with pancreatic cancer in China","volume":"5","author":"Yin","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hpb.2022.09.003_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141562","article-title":"Association between the BsmI polymorphism in the vitamin D receptor gene and breast cancer risk: results from a Pakistani case-control study","volume":"10","author":"Rashid","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2022.09.003_bib22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.4143\/crt.2018.356","article-title":"Prevalence of PALB2 germline mutations in early-onset and familial breast\/ovarian cancer patients from Pakistan","volume":"51","author":"Rashid","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.hpb.2022.09.003_bib23","doi-asserted-by":"crossref","first-page":"D1039","DOI":"10.1093\/nar\/gkx1039","article-title":"VarCards: an integrated genetic and clinical database for coding variants in the human genome","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hpb.2022.09.003_bib24","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hpb.2022.09.003_bib25","first-page":"405","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the","volume":"17","author":"Richards","year":"2015","journal-title":"American College of Medical Genetics and Genomics and the Association for Molecular Pathology"},{"issue":"suppl","key":"10.1016\/j.hpb.2022.09.003_bib26","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.2017.35.15_suppl.1529","article-title":"Pathogenicity of mutation analyzer (PathoMAN): a fast automation of germline genomic variant curation in clinical sequencing","volume":"35","author":"Joseph","year":"2017","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.hpb.2022.09.003_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","article-title":"InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines","volume":"100","author":"Li","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.hpb.2022.09.003_bib28","article-title":"Clinical significance of germline cancer predisposing variants in unselected patients with pancreatic adenocarcinoma","volume":"13","author":"Fountzilas","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2022.09.003_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cancergen.2016.03.003","article-title":"Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic","volume":"209","author":"Borecka","year":"2016","journal-title":"Cancer Genet"},{"issue":"17","key":"10.1016\/j.hpb.2022.09.003_bib30","article-title":"Prevalence of germline pathogenic variants in cancer predisposing genes in Czech and Belgian pancreatic cancer patients","volume":"13","author":"Wieme","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2022.09.003_bib31","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s10897-018-0212-1","article-title":"Comparison of practice guidelines, BRCAPRO, and genetic counselor estimates to identify germline BRCA1 and BRCA2 mutations in pancreatic cancer","volume":"27","author":"Grant","year":"2018","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.hpb.2022.09.003_bib32","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jnci\/djy024","article-title":"Prospective evaluation of germline alterations in patients with exocrine pancreatic neoplasms","volume":"110","author":"Lowery","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"17","key":"10.1016\/j.hpb.2022.09.003_bib33","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1002\/cncr.31628","article-title":"Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma","volume":"124","author":"Brand","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2022.09.003_bib34","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1002\/cncr.29664","article-title":"Identification of germline genetic mutations in patients with pancreatic cancer","volume":"121","author":"Salo-Mullen","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2022.09.003_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102675","article-title":"A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants","volume":"53","author":"Earl","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.hpb.2022.09.003_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/gim.2017.85","article-title":"Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history","volume":"20","author":"Chaffee","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.hpb.2022.09.003_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.trecan.2020.10.002","article-title":"PALB2 variants: protein domains and cancer susceptibility","volume":"7","author":"Nepomuceno","year":"2021","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.hpb.2022.09.003_bib38","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1038\/s41467-019-13194-2","article-title":"Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2","volume":"10","author":"Boonen","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.hpb.2022.09.003_bib39","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1093\/nar\/gkz780","article-title":"A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor","volume":"47","author":"Rodrigue","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hpb.2022.09.003_bib40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/humu.22022","article-title":"Rare germline mutations in PALB2 and breast cancer risk: a population-based study","volume":"33","author":"Tischkowitz","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.hpb.2022.09.003_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067538","article-title":"Analysis of PALB2 gene in BRCA1\/BRCA2 negative Spanish hereditary breast\/ovarian cancer families with pancreatic cancer cases","volume":"8","author":"Blanco","year":"2013","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.hpb.2022.09.003_bib42","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1002\/cncr.30802","article-title":"Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50","volume":"123","author":"Chandrasekharappa","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2022.09.003_bib43","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamaoncol.2016.5194","article-title":"Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer","volume":"3","author":"Pearlman","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.hpb.2022.09.003_bib44","article-title":"Investigation of PALB2 mutation and correlation with immunotherapy biomarker in Chinese non-small cell lung cancer patients","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.hpb.2022.09.003_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008977","article-title":"Systematic identification of functional SNPs interrupting 3\u2032UTR polyadenylation signals","volume":"16","author":"Shulman","year":"2020","journal-title":"PLos Genet"},{"key":"10.1016\/j.hpb.2022.09.003_bib46","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3892\/ol.2021.12485","article-title":"PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma","volume":"21","author":"Ge","year":"2021","journal-title":"Oncol Lett"},{"key":"10.1016\/j.hpb.2022.09.003_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12029-013-9479-5","article-title":"Ampulla of vater adenocarcinoma in a BRCA2 germline mutation carrier","volume":"45","author":"Aburjania","year":"2014","journal-title":"J\u00a0Gastrointest Cancer"},{"key":"10.1016\/j.hpb.2022.09.003_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13053-019-0125-5","article-title":"Spectrum and prevalence of BRCA1\/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study","volume":"17","author":"Rashid","year":"2019","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.hpb.2022.09.003_bib49","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1002\/ijc.22269","article-title":"Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients","volume":"119","author":"Rashid","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hpb.2022.09.003_bib50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10549-014-2972-0","article-title":"Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan","volume":"145","author":"Rashid","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.hpb.2022.09.003_bib51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10689-012-9509-7","article-title":"Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients","volume":"11","author":"Rashid","year":"2012","journal-title":"Fam Cancer"},{"key":"10.1016\/j.hpb.2022.09.003_bib52","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2407-13-312","article-title":"Constitutional CHEK2 mutations are infrequent in early-onset and familial breast\/ovarian cancer patients from Pakistan","volume":"13","author":"Rashid","year":"2013","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.hpb.2022.09.003_bib53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13053-020-00159-6","article-title":"Prevalence of RECQL germline variants in Pakistani early-onset and familial breast cancer patients","volume":"18","author":"Rashid","year":"2020","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.hpb.2022.09.003_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2020.100032","article-title":"Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort","volume":"6","author":"Peretti","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.hpb.2022.09.003_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-020-0163-1","article-title":"Prevalence of disease-causing genes in Japanese patients with BRCA1\/2-wildtype hereditary breast and ovarian cancer syndrome","volume":"6","author":"Kaneyasu","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.hpb.2022.09.003_bib56","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.3390\/cancers13164195","article-title":"Germline PALB2 mutation in high-risk Chinese breast and\/or ovarian cancer patients","volume":"13","author":"Kwong","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.hpb.2022.09.003_bib57","first-page":"9","article-title":"Current and emerging techniques for diagnostic mutation detection","author":"Taylor","year":"2004","journal-title":"Molecular Diagnosis of Genetic Diseases"},{"key":"10.1016\/j.hpb.2022.09.003_bib58","series-title":"Contribution of large genomic rearrangements in PALB2 to familial breast cancer: implications for genetic testing","author":"Li","year":"2022"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X22015933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X22015933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:40:24Z","timestamp":1761266424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X22015933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1365182X22015933"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2022.09.003","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of germline PALB2 variants to an unselected and prospectively registered pancreatic cancer patient cohort in Pakistan","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2022.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}